These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. D-penicillamine in the treatment of localized scleroderma. Falanga V; Medsger TA Arch Dermatol; 1990 May; 126(5):609-12. PubMed ID: 2334179 [TBL] [Abstract][Full Text] [Related]
43. Myasthenia gravis and scleroderma: two cases and a review of the literature. Zivković SA; Medsger TA Clin Neurol Neurosurg; 2007 May; 109(4):388-91. PubMed ID: 17280777 [TBL] [Abstract][Full Text] [Related]
44. Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine. Uitto J; Helin P; Rasmussen O; Lorenzen I Ann Clin Res; 1970 Sep; 2(3):228-34. PubMed ID: 5473163 [No Abstract] [Full Text] [Related]
45. [Hydrocortisone and cuprenil phonophoresis in the therapy of scleroderma]. Dovzhanskaia VS Vestn Dermatol Venerol; 1980 Oct; (10):50-1. PubMed ID: 7003965 [No Abstract] [Full Text] [Related]
46. [Treatment of systemic scleroderma with D-penicillamine. Results in 14 patients treated for more than a year]. Kahn MF; Bourgeois P; Brion N; Elleuch M Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):35-8. PubMed ID: 3704510 [TBL] [Abstract][Full Text] [Related]
47. Two years of penicillamine for progressive systemic sclerosis: a case report. Thomson J; Milne JA Postgrad Med J; 1974 Aug; 50 Suppl 2():36-8. PubMed ID: 4467175 [No Abstract] [Full Text] [Related]
48. [Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma]. Murav'ev IuV; Aliab'eva AP; Sigidin IaA; Guseva NG; Balabanova RM Ter Arkh; 1985; 57(8):125-7. PubMed ID: 3906994 [No Abstract] [Full Text] [Related]
49. [Investigations on the mode of action of D-penicillamine (Metalcaptase) in sclerodermia]. Daróczy J; Gyöngyvér S Munch Med Wochenschr; 1973 Aug; 115(31):1363-7. PubMed ID: 4741080 [No Abstract] [Full Text] [Related]
50. [Drug-induced fever caused by hydroxyurea. Apropos of 3 new cases]. Gallant C; Vial T; Allochon Y; Monier JM; Blanc M; Evreux JC Ann Med Interne (Paris); 1998 Mar; 149(2):59-61. PubMed ID: 11490525 [TBL] [Abstract][Full Text] [Related]
51. [Therapeutic use of d-penicillamine]. Bogdanikowa B Pol Tyg Lek; 1972 Oct; 27(41):1612-3. PubMed ID: 4581541 [No Abstract] [Full Text] [Related]
52. Pancreatitis in systemic scleroderma. Sartori N; Löhr M; Basan B; Holle A; Liebe S Z Gastroenterol; 1997 Sep; 35(9):677-80. PubMed ID: 9360294 [TBL] [Abstract][Full Text] [Related]
53. [Systemic scleroderma associated to a glomerulonephritis with anti-MPO antibodies: a case report and literature review]. Sol EB; Bonkain F; Vande Houtte K; Dratwa M Rev Med Brux; 2008; 29(6):559-67. PubMed ID: 19202712 [TBL] [Abstract][Full Text] [Related]
54. [Treatment of progressive scleroderma using carnitine]. Schneider D Z Gesamte Inn Med; 1974 Jul; 29(13):544-9. PubMed ID: 4281970 [No Abstract] [Full Text] [Related]
56. Drug fever. Tierney L West J Med; 1978 Oct; 129(4):321-6. PubMed ID: 716390 [No Abstract] [Full Text] [Related]
57. Persistent fever in a young woman. Eng PC; Dworakowska D J R Soc Med; 2014 Feb; 107(2):75-8. PubMed ID: 24334909 [TBL] [Abstract][Full Text] [Related]
58. [Fever caused by penicillin. Description of a clinical case]. Baratta E; Biscarini L Clin Ter; 1990 Feb; 132(3):201-2. PubMed ID: 2139830 [TBL] [Abstract][Full Text] [Related]
59. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature. Derk CT; Jimenez SA J Rheumatol; 2003 Jul; 30(7):1616-20. PubMed ID: 12858467 [TBL] [Abstract][Full Text] [Related]
60. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature. Devogelaer JP; Pirson Y; Vandenbroucke JM; Cosyns JP; Brichard S; Nagant de Deuxchaisnes C J Rheumatol; 1987 Oct; 14(5):1036-41. PubMed ID: 3430507 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]